As the world becomes increasingly uncertain, Biora Therapeutics Inc. (BIOR) offers stability

The closing price of Biora Therapeutics Inc. (NASDAQ: BIOR) was $4.20 for the day, up 4.22% from the previous closing price of $4.03. In other words, the price has increased by $+0.1700 from its previous closing price. On the day, 1083808 shares were traded. BIOR stock price reached its highest trading level at $4.4800 during the session, while it also had its lowest trading level at $3.9300.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…



Our analysis of BIOR’s different ratios will help us gain a deeper understanding of the company.

Upgrades & Downgrades

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jul 05 when Sarna Surbhi sold 7,517 shares for $0.61 per share. The transaction valued at 4,585 led to the insider holds 148,774 shares of the business.

Valuation Measures:

For the stock, the TTM Price-to-Sale (P/S) ratio is 55.38.

Stock Price History:

Over the past 52 weeks, BIOR has reached a high of $52.75, while it has fallen to a 52-week low of $1.95. The 50-Day Moving Average of the stock is 4.8959, while the 200-Day Moving Average is calculated to be 14.5482.

Shares Statistics:

BIOR traded an average of 2.19M shares per day over the past three months and 13.13M shares per day over the past ten days. A total of 8.93M shares are outstanding, with a floating share count of 8.32M. Insiders hold about 1.90% of the company’s shares, while institutions hold 24.00% stake in the company. Shares short for BIOR as of Oct 13, 2022 were 14.21M with a Short Ratio of 0.46M, compared to 14.73M on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 7.62% and a Short% of Float of 8.42%.

Earnings Estimates

The firm’s stock currently is rated by 2 analysts. On average, analysts expect EPS of -$0.07 for the current quarter, with a high estimate of -$0.06 and a low estimate of -$0.09, while EPS last year was -$0.46. The consensus estimate for the next quarter is -$0.07, with high estimates of -$0.06 and low estimates of -$0.09.

Analysts are recommending an EPS of between -$0.22 and -$0.29 for the fiscal current year, implying an average EPS of -$0.25. EPS for the following year is -$0.35, with 2 analysts recommending between -$0.27 and -$0.43.

Revenue Estimates

A total of 2 analysts have provided revenue estimates for BIOR’s current fiscal year. The highest revenue estimate was $400k, while the lowest revenue estimate was $100k, resulting in an average revenue estimate of $250k. In the same quarter a year ago, actual revenue was $25.61M, down -99.00% from the average estimate.